Patents by Inventor Michael Leffak

Michael Leffak has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DNA binding protein
    Patent number: 7851153
    Abstract: Methods of screening for compounds which are, for example, capable of modulating amino acid-DNA interaction, modulating DNA replication, modulating cell proliferation, and for identifying compounds which inhibit cellular proliferation caused by cancer, are provided.
    Type: Grant
    Filed: December 1, 2005
    Date of Patent: December 14, 2010
    Assignee: Wright State University
    Inventors: Michael Leffak, John Casper
  • DNA BINDING PROTEIN
    Publication number: 20090061531
    Abstract: Methods of screening for compounds which are, for example, capable of modulating amino acid-DNA interaction, modulating DNA replication, modulating cell proliferation, and for identifying compounds which inhibit cellular proliferation caused by cancer, are provided.
    Type: Application
    Filed: August 26, 2008
    Publication date: March 5, 2009
    Applicant: WRIGHT STATE UNIVERSITY
    Inventors: Michael Leffak, John Casper
  • DNA binding protein
    Publication number: 20060084108
    Abstract: Methods of screening for compounds which are, for example, capable of modulating amino acid-DNA interaction, modulating DNA replication, modulating cell proliferation, and for identifying compounds which inhibit cellular proliferation caused by cancer, are provided.
    Type: Application
    Filed: December 1, 2005
    Publication date: April 20, 2006
    Inventors: Michael Leffak, John Casper
  • Dna binding protein
    Publication number: 20040219554
    Abstract: The present invention relates to a novel target for use in pharmaceutical assays and, more particularly, to an isolated nucleic acid molecule encoding the human DNA binding protein DUE-B, antibodies or antibody derivatives that react with DUE-B, the preparation of cloned and purified DUE-B from bacterial and eukaryotic cells, and the preparation of modified forms of DUE-B fused or not to other polypeptides.
    Type: Application
    Filed: February 26, 2004
    Publication date: November 4, 2004
    Inventors: Michael Leffak, John Casper